viforpharma - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here

VFMCRP and ChemoCentryx report positive data for avacopan

The Phase III ADVOCATE trial assessed avacopan in a total of 331 patients. Credit: Vifor Pharma Management Ltd.